The Dopamine Theory of Attention Deficit Hyperactivity Disorder (ADHD)
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Clinical, animal and neuroanatomical studies of differential isomer and dosage effects of CNS stimulant medications on behaviour are reviewed. Wender's hypothesis that an underlying biochemical abnormality and a disorder of reinforcement was the primary deficit in “MBD” children is restated in terms of a disorder of polysynaptic dopaminergic circuits, between prefrontal and striate centres. Wender's notion of a disorder of reinforcement is broadened to include a disorder of planning and correction of behaviour, including capacity for cortical control of automatic instinctual motor programmes. The dopamine hypothesis of Attention Deficit Hyperactivity Disorder (ADHD) is examined from the point of view of differential dose effects of CNS stimulant medications, and theories of neural control. Clinical, animal and neurophar-macological studies are reviewed. Implications of the findings for understanding clinical and side effects in ADHD children of stimulants are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The DA hypothesis of ADHD was proposed decades ago (Levy, 1991;Wender, 1971), based partially on the hypothesis that stimulants acted as DA agonist drugs and that the increase in synaptic DA was a critical factor in the response to stimulant medication.”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Levy, 1991
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
(2024) · Pharmacological Reviews · doi:10.1124/pr · Cited by 2,664
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Arousal, activation, and effort in the control of attention.
Pribram, K. H., & McGuinness, D. (1975) · Psychological Review · doi:10.1037/h0076780 · Cited by 1,208
Asymmetric neural control systems in human self-regulation.
Tucker, D. M., & Williamson, P. A. (1984) · Psychological Review · doi:10.1037//0033-295x.91.2.185 · Cited by 781
Minimal brain dysfunction in children
(1971) · Behavior Therapy · doi:10.1016/s0005-7894(71)80127-2 · Cited by 773
Striatal Dysfunction in Attention Deficit and Hyperkinetic Disorder
Lou, H. C., Henriksen, L., Bruhn, P., Borner, H., & Nielsen, J. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520370050018 · Cited by 549
Skirboll, L. R., Grace, A. A., & Bunney, B. S. (1979) · Science · doi:10.1126/science.482929 · Cited by 501
Focal Cerebral Hypoperfusion in Children With Dysphasia and/or Attention Deficit Disorder
Lou, H. C., Henriksen, L., & Bruhn, P. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050190031010 · Cited by 495
Pharmacology of mesocortical dopamine neurons.
Bannon, M. J., & Roth, R. H. (1983) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06572-x · Cited by 488
COYLE, J. T., & SNYDER, S. H. (1969) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28416-6 · Cited by 453
Sprague, R. L., & Sleator, E. K. (1977) · Science · doi:10.1126/science.337493 · Cited by 441
BUNNEY, B. S., AGHAJANIAN, G. K., & ROTH, R. H. (1973) · Nature New Biology · doi:10.1038/newbio245123a0 · Cited by 434
Neurobiology of Attention Deficit Disorder With Hyperactivity: Where Have We Come in 50 Years?
ZAMETKIN, A. J., & RAPOPORT, J. L. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198709000-00011 · Cited by 348
HUNT, R. D., MINDERAA, R. B., & COHEN, D. J. (1985) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60065-0 · Cited by 313
A Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. Efficacy
BIEDERMAN, J., BALDESSARINI, R. J., WRIGHT, V., KNEE, D., & HARMATZ, J. S. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00022 · Cited by 310
The role of noradrenaline in tuning and dopamine in switching between signals in the CNS
Oades, R. D. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90050-8 · Cited by 306
Taylor, K. M., & Snyder, S. H. (1970) · Science · doi:10.1126/science.168.3938.1487 · Cited by 251
Stimulant Medications Precipitate Tourette's Syndrome
Lowe, T. L. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320370043028 · Cited by 248
Minimal Brain Dysfunction in Children.
GRANT, D. K. (1971) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1971.02110050131025 · Cited by 236
Harris, J. E., & Baldessarinig, R. J. (1973) · Neuropharmacology · doi:10.1016/0028-3908(73)90120-2 · Cited by 213
The mesocortico-prefrontal dopaminergic neurons
Glowinski, J., Tassin, J. P., & Thierry, A. M. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80145-9 · Cited by 192
Imaging of Neurotransmitter Receptors in the Living Human Brain
Sedvall, G. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100089012 · Cited by 179
Gittelman-Klein, R. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770100079008 · Cited by 177
Robbins, T. W., & Sahakian, B. J. (1979) · Neuropharmacology · doi:10.1016/0028-3908(79)90157-6 · Cited by 170
Brain Dopamine Systems and Behavior
Iversen, S. D. (1977) · Drugs, Neurotransmitters, and Behavior · doi:10.1007/978-1-4684-3180-3_8 · Cited by 167
Methylphenidate and Haloperidol in Children: Effects on Attention, Memory, and Activity
Werry, J. S. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760240118009 · Cited by 162
Zametkin, A. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330049006 · Cited by 151
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1977) · Springer eBooks · doi:10.1007/978-1-4613-4214-4 · Cited by 138
Organic Drivenness a Brain-Stem Syndrome and an Experience
Kahn, E., & Cohen, L. (1934) · New England Journal of Medicine · doi:10.1056/nejm193404052101405 · Cited by 134
Tassin, J., Bockaert, J., Blanc, G. ́., Stinus, L., Thierry, A. M., Lavielle, S., Pre´mont, J., & Glowinski, J. (1978) · Brain Research · doi:10.1016/0006-8993(78)90698-4 · Cited by 128
Treatment of Hyperactive Children With Monoamine Oxidase Inhibitors: I. Clinical Efficacy
Zametkin, A. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330042005 · Cited by 127
Costall, B., & Naylor, R. J. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90348-4 · Cited by 124
Solanto, M. V. (1984) · Psychological Bulletin · doi:10.1037/0033-2909.95.3.387 · Cited by 121
A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats
Robbins, T. W., & Iversen, S. D. (1973) · Psychopharmacology · doi:10.1007/bf00421400 · Cited by 120
Arnold, L. E. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750300078015 · Cited by 102
Schwartz, M. L., & Goldman, P. S. (1982) · Nature · doi:10.1038/299154a0 · Cited by 98
Tassin, J., Simon, H., Hervé, D., Blanc, G., Moal, M. L., Glowinski, J., & Bockaert, J. (1982) · Nature · doi:10.1038/295696a0 · Cited by 83
&NA; (1989) · Behavioural Pharmacology · doi:10.1097/00008877-198923000-00001 · Cited by 83
Does Methylphenidate Constrict Cognitive Functioning?
Solanto, M. V., & Wender, E. H. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198911000-00014 · Cited by 76
Arnold, L. E. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030012002 · Cited by 75
Moal, M. L., Galey, D., & Cardo, B. (1975) · Brain Research · doi:10.1016/0006-8993(75)90972-5 · Cited by 72
ARNOLD, L. E., KIRILCUK, V., CORSON, S. A., & CORSON, E. O. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.2.165 · Cited by 66
Clark, T. K. (1979) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(79)90393-5 · Cited by 48
Stimulant Medications Precipitate Tourette's Syndrome
Lowe, T. L. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320330064029 · Cited by 43
Lévy, F., & Hobbes, G. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198811000-00025 · Cited by 39
Psychiatry and the biology of the human brain
Geffen, L. B. (1983) · Trends in Neurosciences · doi:10.1016/0166-2236(83)90058-9 · Cited by 34
Are the effects of psychomotor stimulant drugs on hyperactive children really paradoxical?
Sahakian, B. J., & Robbins, T. W. (1977) · Medical Hypotheses · doi:10.1016/0306-9877(77)90065-2 · Cited by 29
Peachey, J., Rogers, B., & Brien, J. (1977) · Psychopharmacology · doi:10.1007/bf00431729 · Cited by 14
WERRY, J. S. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198801000-00022 · Cited by 10
Burton, P. G. (1990) · Psychobiology · doi:10.3758/bf03327226 · Cited by 7
Research works printed but not linked: 5
- Still GF, 1902, Lancet, 1008
- Donnely M, 1986, Clinical Pharmacology and Therapeuties, 39, 71
- Taylor KM, 1970, Brain Research, 295
- 10.1037/0033-295x.91.2.185 · doi:10.1037/0033-295x.91.2.185 · Paper page
- Glowinsky J, 1984, TINS, 415
Cited by
Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
Castellanos, F. X. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070053009 · Cited by 1,183
Hypersexual disorder: A proposed diagnosis for DSM-V
Kafka, M. P. (2010) · Archives of Sexual Behavior · doi:10.1007/s10508-009-9574-7 · Cited by 1,095
“…1987), and impulsivity disorders (Kavoussi, Armstead, & Coccaro, 1997; Soubrie, 1986) as well as attention deficit hyperactivity disorders (Levy, 1991) are associated with perturbations of central monoaminergic neurotransmission as well, thereby providing a possible neurobiological bridge…”
BackgroundCandidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Alcaro, A., Huber, R., & Panksepp, J. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.07.014 · Cited by 616
“…have been proposed to explain addiction (Wise and Bozarth, 1981, 1987; Koob, 1992), attention deficit hyperactivity disorder (ADHD) (Oades, 1987; Levy, 1991; Russell, 2000), and depression (Willner, 1983a,b; Dailly et al., 2004) as well as global behavioral activation (Gray, 1995) ranging from…”
BackgroundSwanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G. A., Volkow, N., Taylor, E., Casey, B. J., Castellanos, F. X., & Wadhwa, P. D. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9019-9 · Cited by 580
“For example, while Levy (1991) proposed the DA deficit hypothesis, with post-synaptic effects that amplified the DA neural response, Solanto (1998) proposed a DA excess hypothesis, with presynaptic effects of stimulant medication reducing release and reducing the DA neural response. The modern update of the presynapti…”
BackgroundMethodInfluential
Metadata
- Authors
- Levy, F.
- Affiliations
- Department of Child and Adolescent Psychiatry, University of New South Wales and Prince of Wales Children's Hospital, Randwick, NSW
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 1991-06
- Volume
- 25
- Issue
- 2
- Pages
- 277-283
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2148462481
- Cited by
- 234
- References
- 52
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 10 · 2023: 3 · 2022: 8 · 2021: 6 · 2020: 9 · 2019: 9 · 2018: 5 · 2017: 8 · 2016: 9 · 2015: 9 · 2014: 16 · 2013: 6 · 2012: 10
- FWCI
- 0.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of California, Irvine
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, dopamine hypothesis, psychostimulants, stimulant side effects
- MeSH terms
- Animals, Attention Deficit Disorder with Hyperactivity, Brain, Brain Mapping, Child, Dopamine, Humans, Synaptic Transmission, Neurons, Receptors, Dopamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.